We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Brazil Establishes Faster Review Times for Some Clinical Trials
Brazil Establishes Faster Review Times for Some Clinical Trials
March 19, 2015
Brazilian regulator Anvisa has set a 90-day timeline for reviewing requests to conduct clinical trials that are also being done in other countries.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor